In the future, people getting ready for a flight — and fearing impending jet lag — might fit an assortment of additions into their carry on: masks, gloves, and maybe a medicinal mushroom hailed for ...

A new pharmacological agent demonstrates promising results for the prevention of a wide range of heart rhythm disorders, including both cardiac and brain injury-induced arrhythmias. Furthermore, the ...

Rhythm Pharmaceuticals, Inc.'s main asset, imcivree, targets rare genetic obesity disorders; key milestones in 2025 could significantly impact the stock. Positive Phase 3 data and expanded indications ...